Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment
Robinson, Philip C, Richards, Duncan, Tanner, Helen L, Feldmann, MarcJournal:
The Lancet Rheumatology
DOI:
10.1016/S2665-9913(20)30309-X
Date:
September, 2020
File:
PDF, 74 KB
2020